#

Roche

: 8
Photo: Taljat David / Shutterstock
News·
A key Novartis drug failed to meet expectations. The stock price fell
Nine major pharma companies have made deals with Trump to lower drug prices
News·
Nine major pharma companies have made deals with Trump to lower drug prices
U.S. to reach drug pricing agreements with Novartis and Roche - Bloomberg
News·
U.S. to reach drug pricing agreements with Novartis and Roche - Bloomberg
Oncology drugmaker Olema triples in a week after latest Roche data eases sector risks
Small Caps·
Oncology drugmaker Olema triples in a week after latest Roche data eases sector risks
Signal to sell: global stocks fall amid investor fatigue and cache shortages
News·
"Signal to sell": global stocks fall amid investor fatigue and cache shortages
Pharma stocks in Europe reacted weakly to Trumps threats of new duties
News·
Pharma stocks in Europe reacted weakly to Trump's threats of new duties
The deal values Poseida at triple its highest market value in the last year. / Photo: Poseida
Small Caps·
Poseida Therapeutics, cell therapy maker, triples on Nasdaq after being acquired by Roche
Scholar Rock plans to file for approval of its SMA drug in 2025 / Photo: bostonglobe.com
Small Caps·
Scholar Rock stock skyrockets on positive trial data for its SMA drug